Arlington, Virginia Clinical Trials
A listing of Arlington, Virginia clinical trials actively recruiting patient volunteers.
Found 101 clinical trials
qa123
dfdf
- 0 views
- 19 Feb, 2024
- +4 other locations
Determinants of Neonatal Anemia in Women Carrying Multiples
Multiple births in the United States are rapidly increasing in large part due to assisted reproductive technologies. Recent data indicate that multiple births now comprise 3-4.5% of all births in the United States. Pregnant women are at risk for iron (Fe) deficiency anemia yet there are virtually no data on …
- 0 views
- 10 Jan, 2025
- +2 other locations
Trial T2 User Test Test1234 (fdg)
dfgfdg
- 0 views
- 24 Apr, 2024
- 1 location
A Study of ADRX-0405 in Subjects with Select Advanced Solid Tumors
The primary purpose of this study is to assess the safety, tolerability, and pharmacokinetics, and to identify the optimal dose of ADRX-0405 in patients with select advanced solid tumors.
- 0 views
- 13 May, 2025
- +2 other locations
change - Safety and Tolerability of TOP-N53 Applied on Digital Ulcers in Patients With Systemic Sclerosis (TOP-N53-02)
change - The main goal of this clinical trial is to learn about how safe the new drug TOP-N53 solution is when it is applied to open wounds on the fingertip (digital ulcers) in people with an uncommon illness that results in hard, thickened areas of skin and additional problems …
- 0 views
- 13 Jun, 2025
- +2 other locations
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
The primary objectives of this study are to evaluate the safety and tolerability of TGW101 and determine the recommended dosing regimen(s) for further study. The secondary objectives are to assess pharmacokinetics and preliminary anti-tumor activity.
- 0 views
- 07 May, 2025
- +1 other locations
Test Trial v7.4
Test Trial v7.4
- 0 views
- 24 Mar, 2026
- 1 location
Regression testing of PS ( DO NOT TOUCH )
Regression testing of PS ( DO NOT TOUCH )
- 0 views
- 25 Mar, 2026
- 1 location
Test Automation Study v7.5.1 (Do not update - Created for migration)
Test Automation Study v7.5.1 (Do not update - Created for migration)
- 0 views
- 03 May, 2026
- +1 other locations
Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel
Background People with rare cancers often have limited treatment options. The biology of rare cancers is not well understood. Researchers want to find better treatments for these cancers. They want to test 2 drugs that, taken separately, have helped people with non-rare cancers. They want to see if these drugs …
- 0 views
- 19 Feb, 2024
- 1 location